Optimizing fusion transcript monitoring in CML

Free article

Comment

Mark Hertzberg et al. Blood. 2007.

Free article

. 2007 Mar 1;109(5):2263; author reply 2263-4.

doi: 10.1182/blood-2006-08-043588.

No abstract available

Comment on

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.
Hughes T, Deininger M, Hochhaus A, Branford S, Radich J, Kaeda J, Baccarani M, Cortes J, Cross NC, Druker BJ, Gabert J, Grimwade D, Hehlmann R, Kamel-Reid S, Lipton JH, Longtine J, Martinelli G, Saglio G, Soverini S, Stock W, Goldman JM. Hughes T, et al. Blood. 2006 Jul 1;108(1):28-37. doi: 10.1182/blood-2006-01-0092. Epub 2006 Mar 7. Blood. 2006. PMID: 16522812 Free PMC article. Review.

Investigation of bcr-abl transcription by Ph-positive chronic myeloid leukemia progenitors.
Keating A. Keating A. Stem Cells. 1993 Oct;11 Suppl 3:31-3. doi: 10.1002/stem.5530110910. Stem Cells. 1993. PMID: 8298475
A novel BCR-ABL rearrangement in a Philadelphia chromosome-positive chronic myelogenous leukaemia variant with thrombocythaemia.
Rubinstein R, Purves LR. Rubinstein R, et al. Leukemia. 1998 Feb;12(2):230-2. doi: 10.1038/sj.leu.2400917. Leukemia. 1998. PMID: 9519786
Detection of BCR/ABL fusion gene in CML: a preliminary report.
Rerkamnuaychoke B, Kangwanpong D, Jootar S, Puranakanitstha C. Rerkamnuaychoke B, et al. Southeast Asian J Trop Med Public Health. 1995;26 Suppl 1:197-200. Southeast Asian J Trop Med Public Health. 1995. PMID: 8629106
Lymphoid preponderance and the absence of basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leukemia.
Hur M, Song EY, Kang SH, Shin DH, Kim JY, Park SS, Cho HI. Hur M, et al. Ann Hematol. 2002 Apr;81(4):219-23. doi: 10.1007/s00277-002-0433-z. Epub 2002 Feb 28. Ann Hematol. 2002. PMID: 11976825 Review.
A case of chronic myeloid leukemia with minor bcr-abl transcript following fluorouracil therapy for esophageal carcinoma.
Nakamura H, Inokuchi K, Hanawa H, Yamaguchi H, Tamura H, Tajika K, Dan K. Nakamura H, et al. Ann Hematol. 2000 Jul;79(7):396-401. doi: 10.1007/s002779900151. Ann Hematol. 2000. PMID: 10965789 Review.